These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21265816)

  • 21. [A Novel mutation of F189L in CASQ2 in families with catecholaminergic polymorphic ventricular tachycardia].
    Liu QQ; Oberti C; Zhang XQ; Ke T; Zhang T; Scheinman M; Hu DY; Wang QK
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):334-7. PubMed ID: 18543230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.
    de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The calsequestrin mutation CASQ2D307H does not affect protein stability and targeting to the junctional sarcoplasmic reticulum but compromises its dynamic regulation of calcium buffering.
    Kalyanasundaram A; Bal NC; Franzini-Armstrong C; Knollmann BC; Periasamy M
    J Biol Chem; 2010 Jan; 285(5):3076-83. PubMed ID: 19920148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2).
    Katz G; Shainberg A; Hochhauser E; Kurtzwald-Josefson E; Issac A; El-Ani D; Aravot D; Afek A; Seidman JG; Seidman CE; Eldar M; Arad M
    Biochem Pharmacol; 2013 Dec; 86(11):1576-83. PubMed ID: 24070655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.
    Novak A; Barad L; Zeevi-Levin N; Shick R; Shtrichman R; Lorber A; Itskovitz-Eldor J; Binah O
    J Cell Mol Med; 2012 Mar; 16(3):468-82. PubMed ID: 22050625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calsequestrin 2 and arrhythmias.
    Faggioni M; Knollmann BC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1250-60. PubMed ID: 22198169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-natal heart adaptation in a knock-in mouse model of calsequestrin 2-linked recessive catecholaminergic polymorphic ventricular tachycardia.
    Valle G; Boncompagni S; Sacchetto R; Protasi F; Volpe P
    Exp Cell Res; 2014 Feb; 321(2):178-89. PubMed ID: 24370574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of sarcoplasmic reticulum calcium release by calsequestrin in cardiac myocytes.
    Györke S; Györke I; Terentyev D; Viatchenko-Karpinski S; Williams SC
    Biol Res; 2004; 37(4):603-7. PubMed ID: 15709687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization.
    Bal NC; Sharon A; Gupta SC; Jena N; Shaikh S; Gyorke S; Periasamy M
    J Biol Chem; 2010 May; 285(22):17188-96. PubMed ID: 20353949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death.
    Terentyev D; Kubalova Z; Valle G; Nori A; Vedamoorthyrao S; Terentyeva R; Viatchenko-Karpinski S; Bers DM; Williams SC; Volpe P; Gyorke S
    Biophys J; 2008 Aug; 95(4):2037-48. PubMed ID: 18469084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2.
    Wleklinski MJ; Kryshtal DO; Kim K; Parikh SS; Blackwell DJ; Marty I; Iyer VR; Knollmann BC
    Circ Res; 2022 Sep; 131(8):673-686. PubMed ID: 36102198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell-type specific expression of Casq2 in the CPVT2 phenotype.
    Flores DJ; Duong T; Brandenberger LO; Mitra A; Shirali A; Johnson JC; Springer D; Noguchi A; Yu ZX; Ebert SN; Ludwig A; Knollmann BC; Levin MD; Pfeifer K
    Hum Mol Genet; 2018 May; 27(9):1533-1544. PubMed ID: 29452352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ANKRD1 specifically binds CASQ2 in heart extracts and both proteins are co-enriched in piglet cardiac Purkinje cells.
    Torrado M; Nespereira B; López E; Centeno A; Castro-Beiras A; Mikhailov AT
    J Mol Cell Cardiol; 2005 Feb; 38(2):353-65. PubMed ID: 15698842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
    Katz G; Arad M; Eldar M
    Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of
    Ng K; Titus EW; Lieve KV; Roston TM; Mazzanti A; Deiter FH; Denjoy I; Ingles J; Till J; Robyns T; Connors SP; Steinberg C; Abrams DJ; Pang B; Scheinman MM; Bos JM; Duffett SA; van der Werf C; Maltret A; Green MS; Rutberg J; Balaji S; Cadrin-Tourigny J; Orland KM; Knight LM; Brateng C; Wu J; Tang AS; Skanes AC; Manlucu J; Healey JS; January CT; Krahn AD; Collins KK; Maginot KR; Fischbach P; Etheridge SP; Eckhardt LL; Hamilton RM; Ackerman MJ; Noguer FRI; Semsarian C; Jura N; Leenhardt A; Gollob MH; Priori SG; Sanatani S; Wilde AAM; Deo RC; Roberts JD
    Circulation; 2020 Sep; 142(10):932-947. PubMed ID: 32693635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Eckey K; Strutz-Seebohm N; Katz G; Fuhrmann G; Henrion U; Pott L; Linke WA; Arad M; Lang F; Seebohm G
    Cell Physiol Biochem; 2010; 26(4-5):503-12. PubMed ID: 21063088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine.
    Sanchez EJ; Hayes RP; Barr JT; Lewis KM; Webb BN; Subramanian AK; Nissen MS; Jones JP; Shelden EA; Sorg BA; Fill M; Schenk JO; Kang C
    Drug Alcohol Depend; 2013 Dec; 133(2):344-51. PubMed ID: 23876860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chain-reaction Ca(2+) signaling in the heart.
    Györke S; Hagen BM; Terentyev D; Lederer WJ
    J Clin Invest; 2007 Jul; 117(7):1758-62. PubMed ID: 17607353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model.
    Rizzi N; Liu N; Napolitano C; Nori A; Turcato F; Colombi B; Bicciato S; Arcelli D; Spedito A; Scelsi M; Villani L; Esposito G; Boncompagni S; Protasi F; Volpe P; Priori SG
    Circ Res; 2008 Aug; 103(3):298-306. PubMed ID: 18583715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of calsequestrin in atrial and ventricular muscle of thermally acclimated rainbow trout.
    Korajoki H; Vornanen M
    J Exp Biol; 2009 Nov; 212(Pt 21):3403-14. PubMed ID: 19837881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.